DK557787A - Peroralt praeparat til administrering af bioaktive midler via den peyerske plaques - Google Patents

Peroralt praeparat til administrering af bioaktive midler via den peyerske plaques

Info

Publication number
DK557787A
DK557787A DK557787A DK557787A DK557787A DK 557787 A DK557787 A DK 557787A DK 557787 A DK557787 A DK 557787A DK 557787 A DK557787 A DK 557787A DK 557787 A DK557787 A DK 557787A
Authority
DK
Denmark
Prior art keywords
administration
bioactive agents
peyers
plaques
peroral preparation
Prior art date
Application number
DK557787A
Other languages
English (en)
Other versions
DK557787D0 (da
DK175859B1 (da
Inventor
Thomas R Tice
Richard M Gilley
Jay K Staas
John H Eldridge
Original Assignee
Southern Res Inst
Uab Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36954601&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK557787(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Southern Res Inst, Uab Res Found filed Critical Southern Res Inst
Publication of DK557787D0 publication Critical patent/DK557787D0/da
Publication of DK557787A publication Critical patent/DK557787A/da
Application granted granted Critical
Publication of DK175859B1 publication Critical patent/DK175859B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK198705577A 1986-10-24 1987-10-23 Peroralt præparat til administrering af bioaktive midler via de Peyerske plaques samt anvendelse af et antigen til fremstilling af et peroralt præparat DK175859B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US92315986A 1986-10-24 1986-10-24
US92315986 1986-10-24
CN95100893A CN1111157A (zh) 1986-10-24 1995-03-08 用于到达派亚氏淋巴结的口服生物活性剂的制法和配方
CN95100893 1995-03-08

Publications (3)

Publication Number Publication Date
DK557787D0 DK557787D0 (da) 1987-10-23
DK557787A true DK557787A (da) 1988-04-25
DK175859B1 DK175859B1 (da) 2005-04-11

Family

ID=36954601

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198705577A DK175859B1 (da) 1986-10-24 1987-10-23 Peroralt præparat til administrering af bioaktive midler via de Peyerske plaques samt anvendelse af et antigen til fremstilling af et peroralt præparat

Country Status (15)

Country Link
EP (1) EP0266119B2 (da)
JP (1) JP2741728B2 (da)
KR (1) KR900003559B1 (da)
CN (1) CN1111157A (da)
AT (1) ATE108650T1 (da)
AU (1) AU607439B2 (da)
CA (1) CA1331738C (da)
DE (1) DE3750247T2 (da)
DK (1) DK175859B1 (da)
ES (1) ES2056068T3 (da)
HK (1) HK122495A (da)
IE (1) IE64786B1 (da)
IL (1) IL84167A (da)
NZ (1) NZ222278A (da)
ZA (1) ZA877946B (da)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ217821A (en) * 1985-10-10 1989-07-27 Biotech Australia Pty Ltd Oral delivery system; complex of active agent and vitamin b12 or analogue thereof
US5811128A (en) * 1986-10-24 1998-09-22 Southern Research Institute Method for oral or rectal delivery of microencapsulated vaccines and compositions therefor
US5075109A (en) * 1986-10-24 1991-12-24 Southern Research Institute Method of potentiating an immune response
US5807832A (en) * 1987-06-09 1998-09-15 Biotech Australia Pty Limited Oral delivery of biologically active substances bound to vitamin B12
JP2664906B2 (ja) * 1987-08-13 1997-10-22 ストール・リサーチ・アンド・デイベロップメント・コーポレーション 改良された哺乳類の免疫法
US5444113A (en) * 1988-08-08 1995-08-22 Ecopol, Llc End use applications of biodegradable polymers
AU642932B2 (en) * 1989-11-06 1993-11-04 Alkermes Controlled Therapeutics, Inc. Protein microspheres and methods of using them
JP3249147B2 (ja) * 1990-06-01 2002-01-21 キリン−アムジエン・インコーポレーテツド 生理活性蛋白含有経口製剤
US6159502A (en) * 1991-04-02 2000-12-12 Biotech Australia Pty Ltd Oral delivery systems for microparticles
US5912015A (en) 1992-03-12 1999-06-15 Alkermes Controlled Therapeutics, Inc. Modulated release from biocompatible polymers
US6514533B1 (en) 1992-06-11 2003-02-04 Alkermas Controlled Therapeutics, Inc. Device for the sustained release of aggregation-stabilized, biologically active agent
WO1994007469A1 (en) * 1992-09-25 1994-04-14 Dynagen, Inc. An immunobooster for delayed release of immunogen
WO1995011009A1 (en) * 1993-10-22 1995-04-27 Genentech, Inc. Method for preparing microspheres comprising a fluidized bed drying step
US6080429A (en) * 1993-10-25 2000-06-27 Genentech, Inc. Method for drying microspheres
US6913767B1 (en) 1993-10-25 2005-07-05 Genentech, Inc. Compositions for microencapsulation of antigens for use as vaccines
JP3645906B2 (ja) * 1993-11-19 2005-05-11 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ マイクロカプセル封入された３−ピペリジニル−置換１，２−ベンズイソオキサゾール類及び１，２−ベンズイソチアゾール類
US5902565A (en) * 1993-12-24 1999-05-11 Csl Limited Spray dried vaccine preparation comprising aluminium adsorbed immunogens
US6531156B1 (en) 1994-04-15 2003-03-11 Temple University Aqueous solven encapsulation method, apparatus and microcapsules
KR100201352B1 (ko) * 1995-03-16 1999-06-15 성재갑 단일주사 백신 제형
US6265389B1 (en) 1995-08-31 2001-07-24 Alkermes Controlled Therapeutics, Inc. Microencapsulation and sustained release of oligonucleotides
JP2000507912A (ja) * 1995-08-31 2000-06-27 アルカームズ コントロールド セラピューティックス，インコーポレイテッド 作用剤の徐放性組成物
AU717113B2 (en) 1995-11-09 2000-03-16 Health Protection Agency Microencapsulated DNA for vaccination and gene therapy
US6270795B1 (en) 1995-11-09 2001-08-07 Microbiological Research Authority Method of making microencapsulated DNA for vaccination and gene therapy
DE19545257A1 (de) * 1995-11-24 1997-06-19 Schering Ag Verfahren zur Herstellung von morphologisch einheitlichen Mikrokapseln sowie nach diesem Verfahren hergestellte Mikrokapseln
US5980948A (en) * 1996-08-16 1999-11-09 Osteotech, Inc. Polyetherester copolymers as drug delivery matrices
US5783567A (en) * 1997-01-22 1998-07-21 Pangaea Pharmaceuticals, Inc. Microparticles for delivery of nucleic acid
US6197229B1 (en) * 1997-12-12 2001-03-06 Massachusetts Institute Of Technology Method for high supercoiled DNA content microspheres
US6406719B1 (en) 1998-05-13 2002-06-18 Microbiological Research Authority Encapsulation of bioactive agents
GB9810236D0 (en) 1998-05-13 1998-07-08 Microbiological Res Authority Improvements relating to encapsulation of bioactive agents
CA2335460A1 (en) 1998-06-18 1999-12-23 Johns Hopkins University School Of Medicine Polymers for delivery of nucleic acids
US7087236B1 (en) 1998-09-01 2006-08-08 Merrion Research I Limited Method for inducing a cell-mediated immune response and improved parenteral vaccine formulations thereof
CA2341352C (en) 1998-09-01 2013-01-08 Elan Corporation Plc Oral vaccine compositions
WO2000045847A1 (en) 1999-02-05 2000-08-10 Alk-Abelló A/S Novel mucosal delivery system
DK2116257T3 (da) 2000-08-09 2013-02-04 Alk Abello As Parenterale vaccineformuleringer og anvendelser deraf
CA2451741C (en) * 2001-07-02 2014-02-18 Elan Corporation, Plc Peyers's patch and/or m-celle targeting ligands
GB0300881D0 (en) * 2003-01-15 2003-02-12 Secr Defence Therapeutic treatment
JP6334214B2 (ja) * 2013-03-08 2018-05-30 学校法人慶應義塾 レーザーを用いた薬剤放出方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3823228A (en) * 1971-09-29 1974-07-09 Univ Illinois Tge virus vaccine
IL54167A (en) * 1977-03-14 1980-05-30 Baxter Travenol Lab Frangible protective sealing arrangement
AU526320B2 (en) * 1979-04-27 1983-01-06 Acme Fluid Foundry Pty. Ltd. Manway cover fastening assembly
AU567155B2 (en) * 1983-04-15 1987-11-12 Damon Biotech Inc. Capsules for releasing core material at constant rate
DE3465888D1 (en) * 1983-06-22 1987-10-15 Univ Ohio State Res Found Small particle formation and encapsulation
GB2144950A (en) * 1983-08-10 1985-03-13 Philips Electronic Associated Data transmission system

Also Published As

Publication number Publication date
ZA877946B (en) 1988-04-26
DE3750247D1 (de) 1994-08-25
DE3750247T2 (de) 1994-10-27
DK557787D0 (da) 1987-10-23
CA1331738C (en) 1994-08-30
EP0266119B1 (en) 1994-07-20
NZ222278A (en) 1989-09-27
IE64786B1 (en) 1995-09-06
KR900003559B1 (ko) 1990-05-21
AU7992987A (en) 1988-04-28
AU607439B2 (en) 1991-03-07
EP0266119A3 (en) 1989-07-26
IL84167A (en) 1991-04-15
KR880004800A (ko) 1988-06-27
JPS63190833A (ja) 1988-08-08
EP0266119A2 (en) 1988-05-04
CN1111157A (zh) 1995-11-08
DK175859B1 (da) 2005-04-11
ATE108650T1 (de) 1994-08-15
EP0266119B2 (en) 2005-05-04
ES2056068T3 (es) 1994-10-01
JP2741728B2 (ja) 1998-04-22
HK122495A (en) 1995-08-04
IL84167A0 (en) 1988-03-31
IE872851L (en) 1988-04-24

Similar Documents

Publication Publication Date Title
DK557787D0 (da) Peroralt praeparat til administrering af bioaktive midler via den peyerske plaques
ATE144138T1 (de) Arzneimittelzusammensetzung mit kontrollierter wirkstoffabgabe
ATE80996T1 (de) Arzneimittel mit verzoegerter freisetzung.
MX9804008A (es) Formulaciones farmaceuticas.
DK0754452T3 (da) Farmaceutisk præparat i form af en overtrukket kapsel, der frigives i den nedre del af fordøjelsessystemet
DK0752245T3 (da) Biokompatible og bionedbrydelige nanopartikler udviklet til absorption og afgivelse af proteinholdige lægemidler
DE58906926D1 (de) Neue Arzneimittelformulierung sowie Verfahren zu deren Herstellung.
ATE108657T1 (de) Galanthemin enthaltende pharmazeutische formulierung zur behandlung des alkoholismus.
CA2016505A1 (en) Water soluble high molecular polymerized drug preparation
ATE88889T1 (de) Mittel auf gemfibrozilbasis mit modifizierter freigabe.
ATE188219T1 (de) Pharmazeutische dipeptid zusammensetzungen und verwendungsmethoden.
FI951357A0 (fi) Farmaseuttiset koostumukset, jotka mahdollistavat trimetatsidiinin hidastetun vapautumisen oraalisen annostuksen jälkeen
EA199600029A3 (ru) Оральная композиция, содержащая s (+)-этодолак, способ её получения
DE69110740D1 (de) Im Dickdarm zerfallende, Polypeptide enthaltende orale Formulierungen.
ES2194832T3 (es) Formulaciones de ditiazem con absorcion controlada.
DE69015305D1 (de) Stabile immunogene Zusammensetzung.
CA2219777A1 (en) Nanoparticles for oral administration of pharmaceutical agents of low solubility
DK1009380T3 (da) Fremgangsmåde til fremstilling af farmaceutiske formuleringer
SE8701077L (sv) Farmaceutisk beredning
ATE285252T1 (de) Mittel zur verhinderung der truebung der vorderen linsenkapsel
SE8902766D0 (sv) Saett att oeka den farmaceutiska effekten av inositolfosfat samt en beredning med foerbaettrad farmaceutisk effekt

Legal Events

Date Code Title Description
PUP Patent expired